Tag Archives: HIV

Emory pushes forward in AIDS vaccine research

The Bill and Melinda Gates Foundation has awarded Emory with a $6 million grant to continue work towards an AIDS vaccine.  The team, led by Bali Pulendran, PhD and Rafi Ahmed, PhD, includes researchers from across the university, including the Yerkes National Primate Research Center, Emory Vaccine Center, and the Rollins School of Public Health.

The funding will go towards exploring how programming innate immunity can lead to protective antibodies against HIV in a nonhuman primate model, by using nanoparticles that mimic properties of the virus to illicit a response.

For more information about this research and the grant from the Bill and Melinda Gates Foundation, please visit: http://news.emory.edu/stories/2012/09/gates_grant_for_aids_vaccine_research/campus.html.



FDA approves truvada for HIV prevention

On July 16th, 2012, the US Food and Drug Administration approved the first drug for reducing the risk of HIV infection. Gilead Science’s Truvada is actually based in part on technology developed at Emory (Emtriva). In Truvada, a fixed dose of Emtriva (Emtricitabine) is combined with Tenofovir. This exciting news for HIV prophylaxis comes shortly after recent FDA approval of the OraQuick test earlier this month for the detection of HIV using an oral saliva swab.

Visit this link to read more about Truvada and HIV prevention: http://www.huffingtonpost.com/2012/07/16/truvada-fda-hiv-prevent_n_1677020.html